Xizang Haisco Pharmaceutical Group Co Ltd (002653) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥39.68 Million ≈ $5.81 Million USD) by net assets (CN¥4.23 Billion ≈ $618.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Xizang Haisco Pharmaceutical Group Co Lt worth for the company's overall valuation and market capitalisation.
Xizang Haisco Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Xizang Haisco Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Xizang Haisco Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Xizang Haisco Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Xizang Haisco Pharmaceutical Group Co Lt to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SK TELECOM CO.LTD.ADR 5/9
F:KMBA
|
0.085x |
|
LIG Nex1 Co Ltd
KO:079550
|
-0.343x |
|
New York Times Company
NYSE:NYT
|
0.095x |
|
Sociedad Química y Minera de Chile S.A.
SN:SQM-B
|
0.206x |
|
The AES Corporation
NYSE:AES
|
0.128x |
|
Nexchip Semiconductor Corp. A
SHG:688249
|
N/A |
|
News Corp A
NASDAQ:NWSA
|
0.074x |
|
Eurofins Scientific SE
PA:ERF
|
0.220x |
Annual Cash Flow Conversion Efficiency for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2025. View Xizang Haisco Pharmaceutical Group Co Lt stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥4.29 Billion ≈ $627.44 Million |
CN¥786.00 Million ≈ $115.02 Million |
0.183x | +74.26% |
| 2024-12-31 | CN¥4.20 Billion ≈ $614.92 Million |
CN¥442.05 Million ≈ $64.69 Million |
0.105x | -2.42% |
| 2023-12-31 | CN¥4.17 Billion ≈ $610.28 Million |
CN¥449.58 Million ≈ $65.79 Million |
0.108x | +257.25% |
| 2022-12-31 | CN¥3.13 Billion ≈ $458.49 Million |
CN¥94.55 Million ≈ $13.84 Million |
0.030x | +146.13% |
| 2021-12-31 | CN¥2.92 Billion ≈ $427.32 Million |
CN¥35.80 Million ≈ $5.24 Million |
0.012x | -83.03% |
| 2020-12-31 | CN¥2.85 Billion ≈ $417.74 Million |
CN¥206.21 Million ≈ $30.17 Million |
0.072x | -77.54% |
| 2019-12-31 | CN¥2.38 Billion ≈ $347.78 Million |
CN¥764.26 Million ≈ $111.84 Million |
0.322x | +35.70% |
| 2018-12-31 | CN¥1.99 Billion ≈ $291.83 Million |
CN¥472.61 Million ≈ $69.16 Million |
0.237x | +19.17% |
| 2017-12-31 | CN¥1.97 Billion ≈ $288.32 Million |
CN¥391.81 Million ≈ $57.33 Million |
0.199x | +9.11% |
| 2016-12-31 | CN¥2.25 Billion ≈ $328.53 Million |
CN¥409.20 Million ≈ $59.88 Million |
0.182x | -11.28% |
| 2015-12-31 | CN¥2.16 Billion ≈ $315.58 Million |
CN¥443.03 Million ≈ $64.83 Million |
0.205x | -13.86% |
| 2014-12-31 | CN¥2.11 Billion ≈ $308.37 Million |
CN¥502.57 Million ≈ $73.54 Million |
0.238x | -19.15% |
| 2013-12-31 | CN¥1.93 Billion ≈ $281.97 Million |
CN¥568.41 Million ≈ $83.18 Million |
0.295x | +8.40% |
| 2012-12-31 | CN¥1.71 Billion ≈ $249.91 Million |
CN¥464.75 Million ≈ $68.01 Million |
0.272x | -19.89% |
| 2011-12-31 | CN¥767.76 Million ≈ $112.35 Million |
CN¥260.79 Million ≈ $38.16 Million |
0.340x | -58.11% |
| 2010-12-31 | CN¥453.09 Million ≈ $66.30 Million |
CN¥367.38 Million ≈ $53.76 Million |
0.811x | -70.23% |
| 2009-12-31 | CN¥135.17 Million ≈ $19.78 Million |
CN¥368.21 Million ≈ $53.88 Million |
2.724x | +519.97% |
| 2008-12-31 | CN¥214.95 Million ≈ $31.45 Million |
CN¥94.45 Million ≈ $13.82 Million |
0.439x | -- |
About Xizang Haisco Pharmaceutical Group Co Ltd
Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anesthesia and analgesic, endocrine system, enteral parenteral nutrition, cardiovascular, psychiatric, tumor-related, digestive liver, and other diseases. Haisco Pharmaceutical Group Co., Ltd. has licensing and research c… Read more